Loading clinical trials...
Loading clinical trials...
To evaluate the use of the CAMbridge PROstate Biopsy devicE (CAMPROBE) as a method of undertaking prostate biopsy as part of their clinical management.
To assess patient's experience and complications of the CAMPROBE and compare the results with known published outcomes from standard transrectal biopsies . To use data from the pilot study to determine the feasibility of a randomised trial comparing CAMPROBE with the current standard method of prostate biopsies.
Age
18 - 85 years
Sex
MALE
Healthy Volunteers
No
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Start Date
January 1, 2015
Primary Completion Date
December 1, 2015
Completion Date
September 1, 2019
Last Updated
March 2, 2015
50
ESTIMATED participants
CAMPROBE
DEVICE
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
NCT06842498
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494